Contact this trialFirst, we need to learn more about you.
Autophagy Inhibitor
Trametinib + Hydroxychloroquine for Pancreatic Cancer
Recruiting1 awardPhase 1
San Francisco, California
This trial is testing hydroxychloroquine given with trametinib to see if it is effective and has manageable side effects for pancreatic cancer patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service